<DOC>
	<DOCNO>NCT01262170</DOCNO>
	<brief_summary>A randomized , double-blind , active-controlled , crossover , pilot study evaluate safety efficacy CigRx™ Lozenge , dietary supplement , daily smoker temporarily reduce desire smoke</brief_summary>
	<brief_title>A Pilot Study Evaluate Safety Efficacy CigRx™ Smokers</brief_title>
	<detailed_description>Subjects orally self-administer 2 study product , form dissolvable lozenge , complete questionnaire demographic , urge smoke , product rating .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<criteria>Healthy adult smoker Smoking least 5 year Smoking least one ( 1 ) pack cigarette day Allergy lozenge component</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>dietary supplement</keyword>
	<keyword>nutraceutical</keyword>
</DOC>